Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease
Yong Hyun Ha1, Jung Hoon Sung2, Chang Soo Ryu1
1Department of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Republic of Korea.
Insights
Polymorphisms in microRNA-30c (miR-30c) are linked to coronary artery disease (CAD) susceptibility in Koreans. Specific miR-30c and miR-143 genotypes increase CAD risk, especially with metabolic syndrome or diabetes.
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular Disease Research
- Biomarker Discovery
Background:
- Coronary artery disease (CAD) results from plaque buildup in coronary arteries, impeding blood flow.
- PAI-1 gene polymorphisms are linked to CAD, but the role of its 3'-untranslated region and interacting microRNAs (miRNAs) is understudied.
- Understanding post-transcriptional regulation via miRNA-gene interactions is crucial for CAD research.
Purpose of the Study:
- To investigate the association between miRNA polymorphisms targeting the PAI-1 3'-untranslated region and CAD risk in the Korean population.
- To explore the combined effects of specific miRNA genotypes and clinical factors on CAD susceptibility.
- To identify potential miRNA-based prognostic biomarkers for CAD.
Main Methods:
- Genotyping of five polymorphisms in four miRNAs targeting the PAI-1 3'-untranslated region using real-time PCR and TaqMan assays.
- Analysis of genotype and allele combinations for associations with CAD.
- Evaluation of synergistic effects of metabolic syndrome and diabetes mellitus with miRNA polymorphisms on CAD risk.
Main Results:
- The mutant genotype of miR-30c rs928508 (A > G) showed a strong association with increased CAD susceptibility.
- Combined genotypes (homozygous mutant miR-30c rs928508 and wild-type miR-143 rs41291957) and allele combinations (mutant miR-30c rs928508 and wild-type miR-143 rs41291957) significantly increased CAD risk.
- Metabolic syndrome and diabetes mellitus exhibited synergistic effects with miR-30c rs928508 on CAD risk.
Conclusions:
- The miR-30c rs928508 polymorphism is a significant risk factor for CAD in the Korean population.
- Combinations of specific miRNA polymorphisms and clinical factors like metabolic syndrome and diabetes can enhance CAD risk prediction.
- These findings support the use of miRNA polymorphisms as potential prognostic biomarkers for CAD.
Abstract:
Coronary artery disease (CAD) is one of the most common types of cardiovascular disease and can lead to a heart attack as plaque gradually builds up inside the coronary arteries, blocking blood flow. Previous studies have shown that polymorphisms in the PAI-1 gene are associated with CAD; however, studies of the PAI-1 3'-untranslated region, containing a miRNA binding site, and the miRNAs that interact with it, are insufficient. To investigate the association between miRNA polymorphisms and CAD in the Korean population based on post-transcriptional regulation, we genotyped five polymorphisms in four miRNAs targeting the 3'-untranslated region of PAI-1 using real-time PCR and TaqMan assays. We found that the mutant genotype of miR-30c rs928508 A > G was strongly associated with increased CAD susceptibility. In a genotype combination analysis, the combination of the homozygous mutant genotype (GG) of miR-30c rs928508 with the wild-type genotype (GG) of miR-143 rs41291957 resulted in increased risk for CAD. Also, in an allele combination analysis, the combination of the mutant allele (G) of miR-30c rs928508 and the wild-type allele (G) of miR-143 rs41291957 resulted in increased risk for CAD. Furthermore, metabolic syndrome and diabetes mellitus showed synergistic effects on CAD risk when combined with miR-30c rs928508. These results can be applied to identify CAD prognostic biomarkers among miRNA polymorphisms and various clinical factors.
Related Concept Videos
MicroRNAs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Anticoagulant Drugs: Low-Molecular-Weight Heparins


